| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.06 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |